Neuroone Medical Technologies Corp (NASDAQ:NMTC) — Market Cap & Net Worth
Market Cap & Net Worth: Neuroone Medical Technologies Corp (NMTC)
Neuroone Medical Technologies Corp (NASDAQ:NMTC) has a market capitalization of $14.57 Million ($14.57 Million) as of August 3, 2026. Listed on the NASDAQ stock exchange, this USA-based company holds position #26026 globally and #5379 in its home market, demonstrating a -8.65% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Neuroone Medical Technologies Corp's stock price $1.69 by its total outstanding shares 8619876 (8.62 Million). See NMTC capital reinvestment ratio to understand how much of operating cash flow is reinvested back into capital assets.
Neuroone Medical Technologies Corp Market Cap History: 2017 to 2026
Neuroone Medical Technologies Corp's market capitalization history from 2017 to 2026. Data shows change from $103.44 Million to $14.57 Million (-19.57% CAGR).
Index Memberships
Neuroone Medical Technologies Corp is a constituent of 1 market index:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
NASDAQ Composite
IXIC
|
$40.26 Trillion | 0.00% | #2405 of 3165 |
Weight: Neuroone Medical Technologies Corp's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
Neuroone Medical Technologies Corp Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Neuroone Medical Technologies Corp's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.54x
Neuroone Medical Technologies Corp's market cap is 0.54 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2020 | $40.60 Million | $1.93 Million | -$13.64 Million | 21.07x | N/A |
| 2021 | $16.72 Million | $178.15K | -$9.95 Million | 93.87x | N/A |
| 2022 | $10.34 Million | $171.17K | -$10.00 Million | 60.43x | N/A |
| 2023 | $13.62 Million | $1.95 Million | -$11.86 Million | 6.98x | N/A |
| 2024 | $7.12 Million | $3.45 Million | -$12.32 Million | 2.06x | N/A |
| 2025 | $6.53 Million | $12.10 Million | -$3.61 Million | 0.54x | N/A |
Competitor Companies of NMTC by Market Capitalization
Companies near Neuroone Medical Technologies Corp in the global market cap rankings as of August 3, 2026.
Key companies related to Neuroone Medical Technologies Corp by market ranking:
- Abbott Laboratories (NYSE:ABT): Ranked #114 globally with a market cap of $183.80 Billion USD.
- Stryker Corporation (NYSE:SYK): Ranked #189 globally with a market cap of $124.64 Billion USD.
- Medtronic plc (SA:MDTC34): Ranked #233 globally with a market cap of $104.84 Billion USD ( R$534.32 Billion BRL).
- Medtronic PLC (NYSE:MDT): Ranked #238 globally with a market cap of $103.60 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #114 | Abbott Laboratories | NYSE:ABT | $183.80 Billion | $105.70 |
| #189 | Stryker Corporation | NYSE:SYK | $124.64 Billion | $325.70 |
| #233 | Medtronic plc | SA:MDTC34 | $104.84 Billion | R$208.39 |
| #238 | Medtronic PLC | NYSE:MDT | $103.60 Billion | $85.39 |
Neuroone Medical Technologies Corp Historical Marketcap From 2017 to 2026
Between 2017 and today, Neuroone Medical Technologies Corp's market cap moved from $103.44 Million to $ 14.57 Million, with a yearly change of -19.57%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | $14.57 Million | +122.96% |
| 2025 | $6.53 Million | -8.22% |
| 2024 | $7.12 Million | -47.73% |
| 2023 | $13.62 Million | +31.67% |
| 2022 | $10.34 Million | -38.14% |
| 2021 | $16.72 Million | -58.81% |
| 2020 | $40.60 Million | -34.03% |
| 2019 | $61.55 Million | -57.19% |
| 2018 | $143.78 Million | +39.00% |
| 2017 | $103.44 Million | -- |
End of Day Market Cap According to Different Sources
On Aug 3rd, 2026 the market cap of Neuroone Medical Technologies Corp was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $14.57 Million USD |
| MoneyControl | $14.57 Million USD |
| MarketWatch | $14.57 Million USD |
| marketcap.company | $14.57 Million USD |
| Reuters | $14.57 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Neuroone Medical Technologies Corp
NeuroOne Medical Technologies Corporation, a medical technology company, provides solutions for continuous electroencephalogram (cEEG) and stereoelectrocencephalography (sEEG) recording in the United States. The company also provides solutions for spinal cord stimulation, brain stimulation, drug delivery and ablation solutions for patients suffering from epilepsy, trigeminal neuralgia, Parkinson'… Read more